Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Third Eye Asset Management B.V. is an investment management firm located in Amsterdam, Netherlands, founded in 2016. The firm operates the Third Eye Healthcare Fund, which focuses exclusively on the healthcare sector. This includes investments in pharmaceuticals, biotechnology, diagnostics, medical devices, and digital health. The firm is committed to socially responsible investing, aligning its investment performance with stakeholder interests.
As of now, Third Eye manages two investment vehicles: the Third Eye Healthcare Fund, which focuses on public equity, and Third Eye Development, which targets private equity investments in early-stage scientific breakthroughs. The firm has built a reputation for its science-first approach, emphasizing deep scientific diligence in its investment strategies. Third Eye Asset Management has a small but experienced team, collectively claiming over 50 years of expertise in analyzing scientific and clinical data alongside financial markets.
Third Eye Asset Management specializes in investments within the healthcare sector, targeting early-stage scientific breakthroughs. The firm invests across various stages, including pre-seed, seed, seed-plus, Series A, and Series A-plus. Their investment strategy encompasses both public and private equity, focusing on areas such as pharmaceuticals, biotechnology, diagnostics, medical devices, and digital health.
The firm emphasizes a science-first approach, ensuring that all investments are grounded in rigorous scientific diligence. Third Eye seeks to align its investment performance with stakeholder interests, prioritizing risk-sharing and collaboration over traditional fee structures. This unique approach allows them to foster innovation while maintaining a commitment to socially responsible investing.
Third Eye Asset Management has a focused portfolio that includes two notable companies:
Sachin Soni: Founder & Fund Manager. Sachin has a background as an equity research analyst on the Life Sciences team at Kempen & Co, a merchant bank in Amsterdam. He leads all investment activities at Third Eye and has extensive experience in analyzing scientific and clinical data.
Richard van den Broek: Partner for Public & Private Investments. Richard brings expertise in both public and private equity investments, contributing to the firm's strategic direction and investment decisions.
To pitch to Third Eye Asset Management, founders should send an email to info@thirdeyefund.com. It is essential to include a comprehensive pitch deck that outlines the startup's scientific foundation, market opportunity, and alignment with stakeholder interests. The firm prefers detailed information on the technology and its potential impact on the healthcare sector.
Response times may vary, but founders should expect a thorough review process given the firm's emphasis on scientific diligence. Warm introductions are beneficial but not strictly necessary.
As of April 2023, Third Eye Asset Management continues to focus on its investment strategy in the healthcare sector, particularly in early-stage scientific breakthroughs. The firm has maintained its commitment to socially responsible investing and stakeholder alignment.
Recent activities include ongoing support for its portfolio companies, BioTrip and Dextera Biosciences, as they advance their innovative healthcare solutions. The firm remains active in seeking new investment opportunities within Europe, particularly in the Netherlands.
What are Third Eye Asset Management's investment criteria?
The firm focuses on early-stage investments in the healthcare sector, particularly in pharmaceuticals, biotechnology, diagnostics, medical devices, and digital health. They prioritize scientific breakthroughs and transformational technologies.
How can I pitch to Third Eye Asset Management?
Founders can reach out via email at info@thirdeyefund.com. It is advisable to include a detailed pitch deck that outlines the scientific basis of the startup, market potential, and alignment with stakeholder interests.
What makes Third Eye Asset Management different from other investors?
Third Eye emphasizes a science-first approach and prioritizes stakeholder alignment over conventional fee structures. This focus on deep scientific diligence sets them apart from traditional venture capital firms.
What is the geographic focus of Third Eye Asset Management?
The firm primarily invests in Europe, with a specific emphasis on the Netherlands. They are particularly interested in healthcare innovations emerging from this region.
What stages of investment does Third Eye Asset Management engage in?
Third Eye invests across multiple stages, including pre-seed, seed, seed-plus, Series A, and Series A-plus. This allows them to support startups at various points in their development.
What kind of support can portfolio companies expect?
Third Eye Asset Management provides deep scientific diligence and fosters a collaborative environment for innovation. They emphasize risk-sharing and stakeholder alignment, which can enhance the growth potential of portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.